Medipost to conduct first clinical trial of stem cell therapy

Medipost Co., Ltd., one of the nation’s leading bioengineering firms, said on November 2 that it will conduct its Phase I clinical trial of Neurostem, a placenta based embryonic stem cell, for treatment of Alzheimer’s dementia.

According to the company, embryonic stem cells have the potential to develop into other kinds of cells that could possibly be used to treat chronic ailments such as h...